Immunology of Infectious Disease News Volume 9.15 | Apr 21 2021

    0
    47






    IIDN 9.15 | Apr 21 2021


    Immunology of Infectious Disease News by STEMCELL Technologies
    Vol. 9.15 – 21 April, 2021
    TOP STORY

    Adjuvanting a Subunit COVID-19 Vaccine to Induce Protective Immunity

    Scientists demonstrated the capacity of a subunit vaccine, comprising the SARS-CoV-2 spike receptor binding domain displayed on a protein nanoparticle, to stimulate robust and durable neutralizing antibody responses and protection against SARS-CoV-2 in non-human primates.
    [Nature]

    AbstractFull Article

    Request a copy of the COVID-19 wallchart.
    PUBLICATIONSRanked by the impact factor of the journal

    Transmission, Infectivity, and Neutralization of a Spike L452R SARS-CoV-2 Variant

    Investigators identified an emerging SARS-CoV-2 variant by viral whole-genome sequencing of 2,172 nasal/nasopharyngeal swab samples from 44 counties in California.
    [Cell]

    AbstractFull Article

    Single-Cell Multi-Omics Analysis of the Immune Response in COVID-19

    Scientists highlight the coordinated immune response that contributed to COVID-19 pathogenesis and revealed discrete cellular components that could be targeted for therapy.
    [Nature Medicine]

    Full Article

    Increased Resistance of SARS-CoV-2 Variant P.1 to Antibody Neutralization

    Researchers report that another emergent variant from Brazil, P.1, was not only refractory to multiple neutralizing monoclonal antibodies, but also more resistant to neutralization by convalescent plasma and vaccinee sera.
    [Cell Host & Microbe]

    AbstractGraphical Abstract

    Host Barriers to SARS-CoV-2 Demonstrated by Ferrets in a High-Exposure Domestic Setting

    The authors compared SARS-CoV-2 sequences from natural and experimental mustelid infections and identified two surface glycoprotein spike mutations associated with mustelids.
    [Proceedings of the National Academy of Sciences of the United States of America]

    Full Article

    Distinct Uptake, Amplification, and Release of SARS-CoV-2 by M1 and M2 Alveolar Macrophages

    Investigators showed that classically activated M1 alveolar macrophages (AMs) facilitated viral spread; however, alternatively activated M2 AMs limited the spread.
    [Cell Discovery]

    Full Article

    Characterization of Respiratory Microbial Dysbiosis in Hospitalized COVID-19 Patients

    Researchers identified distinct signatures of microbial dysbiosis among severely ill COVID-19 patients on broad spectrum antimicrobial therapy.
    [Cell Discovery]

    Full Article

    Immunogenicity and Efficacy of mRNA COVID-19 Vaccine MRT5500 in Preclinical Animal Models

    The authors describe the efforts to utilize an mRNA platform for rational design and evaluations of mRNA vaccine candidates based on the spike glycoprotein of SARS-CoV-2.
    [npj Vaccines]

    Full Article

    mRNA-Based SARS-CoV-2 Vaccine Candidate CVnCoV Induces High Levels of Virus-Neutralizing Antibodies and Mediates Protection in Rodents

    Investigators showed preclinical data for our clinical candidate CVnCoV, a lipid nanoparticle-encapsulated mRNA vaccine that encoded full-length, pre-fusion stabilized SARS-CoV-2 spike protein.
    [npj Vaccines]

    Full Article

    Modeling SARS-CoV-2 Infection and Its Individual Differences with ACE2-Expressing Human iPS Cells

    Scientists found that human iPS cells expressing the SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2) could be infected with SARS-CoV-2. In infected ACE2-iPS cells, the expression of SARS-CoV-2 nucleocapsid protein, budding of viral particles, production of progeny virus, double membrane spherules, and double-membrane vesicles were confirmed.
    [iScience]

    AbstractGraphical Abstract

    Enhanced Influenza A H1N1 T Cell Epitope Recognition and Cross-Reactivity to Protein-O-Mannosyltransferase 1 in Pandemrix-Associated Narcolepsy Type 1

    The authors showed that pediatric Pandemrix-associated NT1 patients had enhanced T-cell immunity against the viral epitopes, neuraminidase 175–189 and nucleoprotein 214–228.
    [Nature Communications]

    Full Article

    Cellular mRNA Triggers Structural Transformation of Ebola Virus Matrix Protein VP40 to Its Essential Regulatory Form

    Researchers showed that suitable nucleic acid was sufficient to trigger a dynamic transformation of VP40 dimer into the octameric ring.
    [Cell Reports]

    Full ArticleGraphical Abstract

    Mint3 Depletion-Mediated Glycolytic and Oxidative Alterations Promote Pyroptosis and Prevent the Spread of Listeria monocytogenes Infection in Macrophages

    Scientists examined the role of Mint3 in macrophages, which promoted glycolysis via hypoxia-inducible factor-1 activation, during the initiation of pyroptosis following Listeria monocytogenes infection.
    [Cell Death & Disease]

    Full Article

    Explore scientific resources for your immunology research at the STEMCELL Technologies immunology learning center
    REVIEWS

    Neutralizing Monoclonal Antibodies for Treatment of COVID-19

    The authors review the precedent for passive immunization and lessons learned from using antibody therapies for viral infections such as respiratory syncytial virus, Ebola virus and SARS-CoV infections.
    [Nature Reviews Immunology]

    Full Article

    INDUSTRY AND POLICY NEWS

    Trevena Announces TRV027 Selected for Study in Global REMAP-CAP Trial in COVID-19 Patients

    Trevena, Inc. announced that TRV027, the company’s novel AT1 receptor selective agonist, has been selected for inclusion in an international, multi-site, adaptive, Phase II-Phase III trial in COVID-19 patients.
    [Trevena, Inc. (Globe Newswire, Inc.)]

    Press Release

    FEATURED EVENT

    AAI: Immunology 2021

    May 10 – 15, 2021
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Research Fellow – Precision Vaccine Program

    Boston Children’s Hospital – Boston, Massachusetts, United States

    Postdoctoral Position – T Follicular Helper Cell Differentiation

    University of Pennsylvania – Philadelphia, Pennsylvania, United States

    Postdoctoral Position – Gene and Cell Therapy Development for Treatment of Primary Immune Deficiencies

    NIH National Institute of Allergy and Infectious Diseases – Bethesda, Maryland, United States

    Associate Professor – Infectious Disease

    The University of Warwick – Coventry, England, United Kingdom

    New Group Leaders – Microbiology and Infection Biology

    IPBS-Toulouse – Toulouse, France

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Immunology of Infectious Disease News Twitter